Dr. Lowan H. Stewart, MD FACEP
Dr. Stewart is a specialist Emergency Physician, Fellow of the American
College of Emergency Medicine, practicing since 2003 in the US and in
Norway. He trained at the University of New Mexico School of medicine, the
University of Texas at Austin and Oregon Health and Sciences University.
He served as Emergency Department Chair at WFH and as an associate
clinical professor at OHSU. He worked as a board member of the
Norwegian Society of Emergency Medicine to bring the new specialty of
emergency medicine (AMM) to Norway. He was a founder of Santa Fe
Ketamine (now Insight) in New Mexico – the first in the state, Axon Clinic –
the first in Norway, and the first public ketamine treatment unit in
Scandinavia at Sykehuset Østfold. His past research includes studies on
the evolution of emotions and winter depression. He has also studied
complexity theory at the Santa Fe Institute, space medicine, and
international public health. His current research interests include using
novel psychoactive medications in the treatment of mood disorders and
addiction. He is the medical advisor at PsykForsk, DPS Nordre Østfold for
international trials on psilocybin, MDMA, ketamine and esketamine in
collaboration with COMPASS Pathways, the Multidisciplinary Association
for Psychedelic Studies and Janssen. He currently is the Regional Director
of the nordics for Awakn Life Sciences. Dr. Stewart is the co-founder of the
Norwegian Association for Psychedelic Science, a member of the American
Society of Ketamine Physicians and serves as an associate editor for the
Journal of Psychedelic Studies